WithdrawnPhase 4

Brimonidine for Intraoperative Hemostasis

Stopped: Fellow graduated prior to enrollment

United States0Started 2022-05-26

Plain-language summary

The purpose of this study is to observe and report the effects of topical ophthalmic brimonidine in oculofacial plastic surgery.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Above the age of 18 * Ophthalmic conditions requiring oculoplastic surgery Exclusion Criteria: * Known allergy or adverse effects to brimonidine * Hypotony * Acute ophthalmic infection * History of hypotension * Orthostatic hypotension * Pregnancy * History of Central Nervous System (CNS) depression from medication use * Thrombotic disorders * Asymmetrical oculoplastic conditions that may interfere with tear drainage (e.g. unilateral NLDO) * Current use of brimonidine

What they're measuring

Hemostasis

Timeframe: At the time of surgery.

Trial details

NCT IDNCT05480098

SponsorUniversity of Louisville

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-05-22

View on ClinicalTrials.gov More Dermatochalasis of Eyelid trials